Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
Bone marrow-derived mesenchymal stem cells (BMMSCs) have been consider as a promising therapy in fibrotic diseases. Experimental models suggest that BMMSCs may be used as an alternative therapy to treat chemical- or physical-induced pulmonary fibrosis. We investigated the anti-fibrotic potential of...
Main Authors: | Julián Camilo Arango, Juan David Puerta-Arias, Paula Andrea Pino-Tamayo, Lina María Salazar-Peláez, Mauricio Rojas, Ángel González |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5659794?pdf=render |
Similar Items
-
Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
by: Yasunori Iwata, et al.
Published: (2021-05-01) -
TWO-PHASE DYNAMICS OF BONE MARROW MULTIPOTENT MESENCHYMAL STROMAL CELLS (MMSC) ACTION ON LIVER AT MODELING OF FIBROTIC HEPATITIS
by: N. A. Onishchenko, et al.
Published: (2011-06-01) -
Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases
by: Yuling Huang, et al.
Published: (2021-08-01) -
Paracoccidioidomycosis
by: Marcello FRANCO, et al.
Published: (1994-02-01) -
Paracoccidioidomycosis
Published: (1994-04-01)